Showing 1,659 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis & HIV

Hepatitis C: A projection of the healthcare and economic burden in the UK

Editor's pick
RAND Corporation
15 January 2013
Chemsex & recreational drug use

High-risk drug practices tighten grip on London gay scene

Editor's pick
The Lancet
11 January 2013
New & experimental hepatitis C treatment

Roche Scientists Uncover Unexpected Enzyme Activity in HCV RNA Polymerase

Editor's pick
Biospace
11 January 2013
New & experimental hepatitis C treatment

Nucleotide Polymerase Inhibitors - The Search For A Safe Interferon Free Trial

Editor's pick
HCV New Drugs Research
10 January 2013
New & experimental hepatitis C treatment

Idenix May Drop Delayed Hepatitis C Drug for New Versions

Editor's pick
Businessweek
10 January 2013
New & experimental hepatitis C treatment

Gilead Provides Update on Hepatitis C Development Programs

Editor's pick
Gilead press release
8 January 2013
New & experimental hepatitis C treatment

Achillion Reports Interim Results on ACH-3102

Editor's pick
Achillion press release
8 January 2013
Hepatitis C symptoms & diagnosis

Year in Review: Dueling HCV Screening Recommendations

Editor's pick
MedPage Today
3 January 2013
HIV treatment

Top 12 HIV and Hepatitis Stories of 2012

Editor's pick
HIVandHepatitis.com
3 January 2013
Hepatitis C symptoms & diagnosis

UAE to launch Hep-C awareness

Editor's pick
Bahrain News Agency
21 December 2012
New & experimental hepatitis C treatment

Medivir announces phase III data for Simeprevir demonstrating efficacy and safety in genotype 1 hepatitis C patients

Editor's pick
Medivir press release
20 December 2012
Hepatitis C treatment side-effects

Vertex hepatitis C drug Incivek gets 'black box' warning over possible fatal skin conditions

Editor's pick
Washington Post
20 December 2012
New & experimental hepatitis C treatment

Hepatitis C - First Interferon-Free Regimens Expected to Launch in 2014 in the United States and Europe

Editor's pick
HCV New Drugs Research
19 December 2012
Pharmaceutical industry

Breaking Up With Gilead Sciences

Editor's pick
The Street
17 December 2012
Hepatitis C transmission & prevention

HIV+ MSM have 4 times HCV risk of HIV-negative MSM in meta-analysis

Editor's pick
International AIDS Society
17 December 2012
Hepatitis C transmission & prevention

Copy of HIV+ MSM have 4 times HCV risk of HIV-negative MSM in meta-analysis

Editor's pick
International AIDS Society
17 December 2012
Hepatitis C transmission & prevention

HIV11: Sexually transmitted HCV rising among HIV+ gay men in Europe, but more are getting treated

Editor's pick
HIVandhepatitis.com
17 December 2012
Hepatitis C transmission & prevention

Hepatitis C Sexual Transmission Is Rare among Monogamous Heterosexual Couples

Editor's pick
HIVandhepatitis.com
17 December 2012
Hepatitis C treatment

Accessing Hepatitis C Patients Who Are Difficult to Reach

Editor's pick
Medscape (requires registration)
17 December 2012
Hepatitis C treatment

Though Hepatitis C Patients Report Having Equal Influence with Their Treating Physicians Regarding the Management and Treatment of Their Disease, Very Few Have Ever Requested Specific Products for Treatment

Editor's pick
Market Watch (press release)
13 December 2012
Hepatitis C transmission & prevention

New NICE public health guidance aims to ensure more people at increased risk of hepatitis B and C infection are tested

Editor's pick
NICE
12 December 2012
Hepatitis C symptoms & diagnosis

Aging Hepatitis C Population Escalates Demand for Liver Transplantation

Editor's pick
Science Daily
12 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Pharmaceutical industry

Copy of ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
GMI Partnership
6 December 2012